BridgeMD
New treatment option for Presbyacusis
Official title Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
ClinicalTrials.gov ID: NCT05312983
What this study is testing
- What it's testing
- Age-related hearing loss, or presbycusis, is caused by many genetic and environmental factors. Its prevalence poses a public health challenge of early identification and effective hearing aid treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- For all participants:
- Be over the age of 18,
- Be affiliated to a social security system,
- Have a good command of the French language (oral and written). For the group of participants with anticipated presbycusis:
- Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient
You likely can't join if
- Report having been chronically exposed to loud sounds.
- Have a history of ototoxic substances,
- To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance,
- Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied.
- Have type II diabetes,
- Have a neurological or psychiatric condition that interferes with comprehension or ability to move,
See the full eligibility criteria
- For all participants:
- Be over the age of 18,
- Be affiliated to a social security system,
- Have a good command of the French language (oral and written). For the group of participants with anticipated presbycusis:
- Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient
- Between 18 and 40, having a hearing aid recipient, coming for a first hearing aid recipient or declare a progressive genetic birth defect For healthy volunteers: \- Have no known hearing loss.
- Report having been chronically exposed to loud sounds.
- Have a history of ototoxic substances,
- To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance,
- Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied.
- Have type II diabetes,
- Have a neurological or psychiatric condition that interferes with comprehension or ability to move,
- Be under guardianship,
- Be deprived of liberty by judicial or administrative decision, or be subject to legal protection,
- Not being subject to a social security system,
- Taking narcotic substances, alcohol or medication that diminishes cognitive abilities.
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.